These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24084403)

  • 1. Modeling the impact of simulated educational interventions on the use and abuse of pharmaceutical opioids in the United States: a report on initial efforts.
    Wakeland W; Nielsen A; Schmidt TD; McCarty D; Webster LR; Fitzgerald J; Haddox JD
    Health Educ Behav; 2013 Oct; 40(1 Suppl):74S-86S. PubMed ID: 24084403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. System dynamics modeling as a potentially useful tool in analyzing mitigation strategies to reduce overdose deaths associated with pharmaceutical opioid treatment of chronic pain.
    Wakeland W; Schmidt T; Gilson AM; Haddox JD; Webster LR
    Pain Med; 2011 Jun; 12 Suppl 2():S49-58. PubMed ID: 21668757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid addiction, diversion, and abuse in chronic and cancer pain.
    Kata V; Novitch MB; Jones MR; Anyama BO; Helander EM; Kaye AD
    Curr Opin Support Palliat Care; 2018 Jun; 12(2):124-130. PubMed ID: 29465470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of Prescription Opioid Misuse and Projected Overdose Deaths in the United States.
    Chen Q; Larochelle MR; Weaver DT; Lietz AP; Mueller PP; Mercaldo S; Wakeman SE; Freedberg KA; Raphel TJ; Knudsen AB; Pandharipande PV; Chhatwal J
    JAMA Netw Open; 2019 Feb; 2(2):e187621. PubMed ID: 30707224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic model of nonmedical opioid use trajectories and potential policy interventions.
    Wakeland W; Nielsen A; Geissert P
    Am J Drug Alcohol Abuse; 2015; 41(6):508-18. PubMed ID: 25982491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling Mitigation Strategies to Reduce Opioid-Related Morbidity and Mortality in the US.
    Ballreich J; Mansour O; Hu E; Chingcuanco F; Pollack HA; Dowdy DW; Alexander GC
    JAMA Netw Open; 2020 Nov; 3(11):e2023677. PubMed ID: 33146732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics and circumstances of heroin and pharmaceutical opioid overdose deaths: Comparison across opioids.
    Roxburgh A; Hall WD; Gisev N; Degenhardt L
    Drug Alcohol Depend; 2019 Dec; 205():107533. PubMed ID: 31704378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. As opioid overdose deaths reach record highs, call for systematic changes grows louder.
    ED Manag; 2016 Feb; 28(2):13-9. PubMed ID: 26939351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers - United States, 2002-2004 and 2008-2010.
    Jones CM
    Drug Alcohol Depend; 2013 Sep; 132(1-2):95-100. PubMed ID: 23410617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suicide by means of opioid overdose in patients with chronic pain.
    Madadi P; Persaud N
    Curr Pain Headache Rep; 2014 Nov; 18(11):460. PubMed ID: 25249422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamper-resistant drugs cannot solve the opioid crisis.
    Leece P; Orkin AM; Kahan M
    CMAJ; 2015 Jul; 187(10):717-718. PubMed ID: 26124228
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk Factors for Opioid-Use Disorder and Overdose.
    Webster LR
    Anesth Analg; 2017 Nov; 125(5):1741-1748. PubMed ID: 29049118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid Analgesics in Georgia Medicaid: Trends in Potential Inappropriate Prescribing Practices by Demographic Characteristics, 2009-2014.
    Jayawardhana J; Abraham AJ; Perri M
    J Manag Care Spec Pharm; 2018 Sep; 24(9):886-894. PubMed ID: 30156455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid analgesic dose and the risk of misuse, overdose, and death: A narrative review.
    Coyle DT; Pratt CY; Ocran-Appiah J; Secora A; Kornegay C; Staffa J
    Pharmacoepidemiol Drug Saf; 2018 May; 27(5):464-472. PubMed ID: 29243305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of abuse among unintentional pharmaceutical overdose fatalities.
    Hall AJ; Logan JE; Toblin RL; Kaplan JA; Kraner JC; Bixler D; Crosby AE; Paulozzi LJ
    JAMA; 2008 Dec; 300(22):2613-20. PubMed ID: 19066381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized comparison of two web-based interventions on immediate and 30-day opioid overdose knowledge in three unique risk groups.
    Bergeria CL; Huhn AS; Dunn KE
    Prev Med; 2019 Nov; 128():105718. PubMed ID: 31078564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Situating the Continuum of Overdose Risk in the Social Determinants of Health: A New Conceptual Framework.
    Park JN; Rouhani S; Beletsky L; Vincent L; Saloner B; Sherman SG
    Milbank Q; 2020 Sep; 98(3):700-746. PubMed ID: 32808709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study.
    Park TW; Saitz R; Ganoczy D; Ilgen MA; Bohnert AS
    BMJ; 2015 Jun; 350():h2698. PubMed ID: 26063215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Forecasting the opioid epidemic.
    Burke DS
    Science; 2016 Nov; 354(6312):529. PubMed ID: 27811241
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.